High-Risk Skin Cancers With Atezolizumab Plus NT-I7

NCT03901573 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic decision by sponsor

Conditions

Melanoma
Merkel Cell Carcinoma
Cutaneous Squamous Cell Carcinoma

Interventions

DRUG: NT-I7
DRUG: atezolizumab

Sponsor

NeoImmuneTech

Collaborators

[object Object]